Brief: Spago Nanomedical Q2 Loss Widens To SEK 11.6 Mln
Aug 24 (Reuters) - Spago Nanomedical AB (publ) SPAGO.ST :
* APRIL-JUNE NET SALES FOR QUARTER AMOUNTED TO KSEK 267
(KSEK 0)
* Q2 LOSS AT KSEK -11,607 (KSEK -4,764)
Source text for Eikon: ID:nWkr7PBFXg
Further company coverage: SPAGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose